Steven J. Schoch - 11 Jun 2021 Form 4 Insider Report for ARENA PHARMACEUTICALS INC

Role
Director
Signature
/s/ Andrew J. Cronauer, as Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
11 Jun 2021
Net transactions value
$0
Form type
4
Filing time
15 Jun 2021, 17:23:21 UTC
Next filing
25 Jun 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ARNA Common Stock Award $0 +1,533 $0.000000 1,533 11 Jun 2021 Direct F1
transaction ARNA Common Stock Award $0 +3,067 +200% $0.000000 4,600 11 Jun 2021 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ARNA Stock Option (right to buy) Award $0 +3,601 $0.000000 3,601 11 Jun 2021 Common Stock 3,601 $65.19 Direct F3
transaction ARNA Stock Option (right to buy) Award $0 +7,202 $0.000000 7,202 11 Jun 2021 Common Stock 7,202 $65.19 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The amount represents restricted stock units that vest in three equal installments on the dates of Arena's next three annual meetings of stockholders. The shares underlying the restricted stock units will be issued upon vesting and release of the restricted stock units.
F2 The amount represents restricted stock units that vest in full on the earliest of June 11, 2022, or the date of Arena's next annual meeting of stockholders. The shares underlying the restricted stock units will be issued upon vesting and release of the restricted stock units.
F3 The options vest in 36 equal monthly installments (except as otherwise necessary to avoid vesting of a fractional share) over three years beginning on July 11, 2021, and are exercisable once vested.
F4 The options vest in 12 equal monthly installments (except as otherwise necessary to avoid vesting of a fractional share) over one year beginning on July 11, 2021 with the final installment vesting upon the earlier of the one-year anniversary of the grant date or the date of the next annual stockholders' meeting, and are exercisable once vested.